Absci, PrecisionLife collaborate to develop novel biotherapeutics for chronic diseases

Absci (Nasdaq: ABSI), a generative AI drug creation company, and PrecisionLife, a leader in computational biology, today announced a significant collaboration. This partnership is set ... Read More